Antibody therapeutics: A new era for EGFR-mutant NSCLC treatment.

Erbitux (cetuximab) - Eli Lilly

Portrazza (necitumumab) - Eli Lilly

Avastin (bevacizumab) - Roche

http://www.ncbi.nlm.nih.gov/pubmed/42727894

Cheng Zhan; Jiaqi Liang; Junkan Zhu; Xiaolong Huang; Xinran Chen; Yidu Hu; Zongwu Lin

Sep 12, 2026